COGNITIVE AND BEHAVIORAL PRACTICE, published by Elsevier Science Inc, is a prominent peer-reviewed journal focusing on the rapidly evolving field of clinical psychology. With an ISSN of 1077-7229 and an E-ISSN of 1878-187X, this journal has established itself as a key resource for researchers and practitioners alike since its inception in 1994. As of 2023, it proudly holds a Q1 ranking in the Clinical Psychology category, ranked #85 out of 311 according to Scopus, placing it in the 72nd percentile among its peers. The journal aims to disseminate innovative approaches and evidence-based practices within cognitive and behavioral therapy, encouraging robust discussion and dissemination of new findings to enhance clinical practices. Researchers and students engaged in psychological research will find the substantial rigor and depth in its publications invaluable for advancing their knowledge and skills.

EATING DISORDERS, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing the understanding of eating disorders from diverse psychological, medical, and social perspectives. With an ISSN of 1064-0266 and an E-ISSN of 1532-530X, this journal is recognized for its rigorous peer-reviewed research and innovative studies, contributing significantly to the field of clinical psychology and psychiatry. It boasts impressive rankings, including a Q1 classification in Clinical Psychology and a Q1 classification in Medicine (miscellaneous) based on the 2023 category quartiles. Researchers will find its impactful insights invaluable, as it ranks 31st out of 311 in clinical psychology, placing it in the top 10% percentile. Although this journal is not open access, it encompasses a comprehensive range of topics related to eating disorders, fostering a deeper understanding that benefits practitioners, researchers, and students alike. For those dedicated to addressing the complexities of eating disorders, EATING DISORDERS is an essential resource that bridges the gap between research and real-world application.

Psycho-Oncologie is a specialized academic journal dedicated to the intersection of psychology and oncology, published by TECH SCIENCE PRESS. With an ISSN of 1778-3798 and E-ISSN of 1778-381X, this journal serves as an important platform for researchers and practitioners seeking to understand the psychological impact of cancer on patients and their families. Established in 2007 and converging with its findings through 2024, Psycho-Oncologie aims to disseminate high-quality research that enhances mental health and promotes effective treatment strategies within the oncological landscape. Although currently holding a Q4 ranking in disciplines such as Clinical Psychology and Oncology, the journal is committed to maintaining a high standard of research integrity and scientific rigor to foster future advancements. Although it operates under a non-open access model, the journal strives to make its valuable insights available to a broader audience. For those in the fields of psychology, oncology, and health care, Psycho-Oncologie is an essential resource for staying abreast of critical developments and contributing to interdisciplinary approaches in cancer treatment.

JOURNAL OF PSYCHOPHARMACOLOGY, published by SAGE Publications Ltd, is a leading peer-reviewed journal that explores the intricate dynamics of pharmacological interventions in mental health and psychiatry. With an ISSN of 0269-8811 and an E-ISSN of 1461-7285, this esteemed journal has established its reputation in the field since its inception in 1987, converging research excellence into 2024. Recognized as a Q1 journal in various categories including Medicine (miscellaneous), Pharmacology, and Psychiatry and Mental Health, it ranks impressively within the top percentile in Scopus, standing at #64 out of 567 in Psychiatry and Mental Health, and #31 out of 272 in Medical Pharmacology. The journal serves as a vital resource for researchers, professionals, and students, providing insightful articles that advance the understanding of psychopharmacological effects and innovations. Although it does not offer open access, the journal's extensive research and impactful findings make it essential reading for anyone engaged in the field. For those seeking to stay at the forefront of psychopharmacology, the JOURNAL OF PSYCHOPHARMACOLOGY is an invaluable asset.

Musculoskeletal Science and Practice is a premier academic journal published by Elsevier that focuses on the latest advancements in the field of physical therapy, sports therapy, and rehabilitation. With an ISSN of 2468-7812 and an impressive ranking in the Q1 category for 2023, this journal stands out among its peers, being positioned at #69 out of 247 in Scopus rankings within the Health Professions sector, demonstrating a significant impact factor that reflects its importance in the domain. As a dedicated Open Access platform, it aims to disseminate high-quality research and clinical practices to enhance rehabilitation outcomes for patients. The journal, established in the UK and converging its focus from 2017 to 2024, serves as an invaluable resource for professionals, researchers, and students, enabling them to stay informed about innovative practices and evidence-based strategies in musculoskeletal health. With the increasing demands for effective rehabilitation methods in today's healthcare landscape, Musculoskeletal Science and Practice plays a crucial role in shaping the future of therapeutic interventions and advancing the knowledge base in the field.

Deutsche Zeitschrift für Akupunktur is a distinguished journal published by Springer Heidelberg, focusing on the dynamic field of complementary and alternative medicine, with a particular emphasis on acupuncture practices and research. Established in 1984, the journal has been a platform for insightful articles that contribute to the understanding and advancement of acupuncture within the broader context of clinical neurology and medicine. Although its coverage in major databases like Scopus was discontinued in 2017, the journal retains relevance through its unique insights and the depth of its contributions during its operational years. As evidenced by its ranking in the lower quartiles of Scopus for its respective categories, the journal offers an opportunity for emerging scholars and seasoned professionals alike to engage with pioneering research and clinical applications. Importantly, while it does not offer open access, the journal serves as a vital resource for those dedicated to exploring the therapeutic potentials of acupuncture and enhancing patient care through alternative medicine approaches.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

Psychology of Consciousness-Theory Research and Practice, published by the Educational Publishing Foundation, American Psychological Association, serves as a pivotal platform for innovative research at the intersection of psychological theory and practical application. With its ISSN 2326-5523 and E-ISSN 2326-5531, this journal has established itself as a significant contributor to the field since its inception in 2016, continuing to shape discussions on consciousness through diverse psychological lenses. Recognized in 2023 with prestigious rankings such as Q2 in Clinical Psychology and Q2 in Social Psychology, it features rigorous studies that resonate widely among scholars and practitioners alike. Notable for its commitment to open discourse, although not open access, the journal encourages the exchange of ideas while maintaining high academic standards. Researchers and students will find invaluable insights into consciousness studies, informed by the latest empirical findings and theoretical developments, bolstering the journal's reputation as an essential resource for those dedicated to advancing the science of psychology.

Journal of Rational-Emotive and Cognitive-Behavior Therapy, published by Springer, stands as a significant interdisciplinary forum in the field of clinical psychology and experimental and cognitive psychology. With a history spanning from 1983 to 2024, this journal is dedicated to advancing research and practice encapsulating the principles of rational-emotive therapy and cognitive-behavioral approaches. Acknowledged for its impactful contributions, it holds an impressive Q2 ranking in Clinical Psychology and a Q3 ranking in Experimental and Cognitive Psychology as of 2023. The journal serves an essential role in disseminating evidence-based findings that cater to researchers, professionals, and students alike, fostering a deeper understanding of cognitive processes and emotional regulation. We invite you to explore the latest research and case studies, which contribute to the therapeutic landscape, and deepen your knowledge in this evolving field.

JOURNAL OF PSYCHOSOMATIC RESEARCH, published by Pergamon-Elsevier Science Ltd, stands as a premier international forum dedicated to the integration of psychological and physical health. Established in 1956, this esteemed journal has maintained a high impact in the field, currently ranking in the Q1 category for both Clinical Psychology and Psychiatry and Mental Health as of 2023. With an impressive Scopus ranking of #37/311 in Clinical Psychology and #95/567 in Psychiatry and Mental Health, it caters to a wide audience of researchers, clinicians, and students interested in the complex interplay between psychosocial factors and physical health outcomes. The journal publishes a diverse array of original research, reviews, and clinical studies, providing valuable insights into psychosomatic medicine. While it currently does not offer open access options, its robust editorial standards ensure that each publication contributes significantly to advancing the field. As the journal converges into its 68th year, it continues to be at the forefront of psychosomatic research, instrumental in shaping evidence-based practices and enhancing patient care.